Skip to main content
A

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2024-08-09 Declaration of Voting R…
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from Ananda Developments PLC regarding the 'Result of Annual General Meeting'. It provides a table of voting results for various resolutions passed during the meeting. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2024-08-09 English
Graduation to Apex segment of AQSE Growth Market
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from Ananda Developments PLC regarding the company's graduation to the 'Apex' segment of the Aquis Stock Exchange (AQSE). It is a corporate announcement regarding market listing status and does not fit into specific categories like financial reports, dividends, or M&A. As it is a general regulatory announcement that does not fall into the other specific categories provided, it is classified as RNS.
2024-08-05 English
Notice of AGM
AGM Information Classification · 98% confidence The document is an RNS announcement from Ananda Developments PLC regarding the 'Notice of Annual General Meeting'. It provides details on the date, location, and procedures for the upcoming AGM, and mentions that the formal notice is available via a link. While it contains information about a board member's retirement, the primary purpose is to announce the upcoming AGM and the availability of the meeting materials. According to the 'Menu vs Meal' rule, this is an announcement of the meeting materials rather than the full proxy statement or the meeting presentation itself, making it a Proxy Solicitation & Information Statement (PSI) as it serves as the formal notice to shareholders regarding the meeting and voting procedures.
2024-07-16 English
Publication of Annual Report and Accounts
Audit Report / Information Classification · 95% confidence The document is an RNS (Regulatory News Service) announcement from Ananda Developments PLC. It explicitly states 'Completion of Audit & Publication of Annual Report and Accounts' and provides a link to the full report on the company's website. Following the 'Menu vs Meal' rule, because this is a short announcement (under 5,000 characters of core content, excluding the appended financial tables) that serves to notify the market of the publication of the actual Annual Report, it is classified as a Report Publication Announcement (RPA). FY 2024
2024-07-15 English
Invitation to Investor Evening
Regulatory Filings Classification · 98% confidence The document is a short press release (under 5,000 characters) announcing an upcoming 'Investor Evening' event where company executives will engage with investors. It does not contain financial statements, audit reports, or specific regulatory filings, but rather serves as a general corporate announcement regarding investor relations activities. As it does not fit into specific categories like 'Investor Presentation' (which would contain the actual slides/data) or 'Report Publication Announcement', it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement distributed via the RNS Reach service.
2024-07-11 English
Promising Results from Cardiac Fibrosis Studies
Regulatory Filings Classification · 98% confidence The document is a press release issued via the Regulatory News Service (RNS) of the London Stock Exchange by Ananda Developments PLC. It details the results of a preclinical study for a drug candidate (MRX1). While it contains scientific data, it is a corporate announcement of research findings rather than a formal financial report, audit, or proxy statement. As it is a standard regulatory announcement of company news, it falls under the RNS category.
2024-06-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.